The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (11/9/09) is the location to hear about late-breaking data on emerging cancer therapies. This year's conference brings together delegates from all over the world to discuss innovation in drug development, target selection and the impact of new discoveries in molecular and cell biology. To help you plan your coverage of the conference, the program schedule is available online at
www.aacr.org. Although the full abstracts will not be available until the conference, an electronic press kit containing the press releases and select highlighted abstracts will be available to subscribing reporters on Nov. 9, 2009, via Eurekalert and Newswise, and by request to the AACR Communications and Public Relations Department.
More than 1,000 abstracts will be presented for the first time at the conference, complementing an outstanding program of scientific and educational events. The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics attracts world leaders in cancer research and treatment, including clinical oncologists, industry leaders, basic scientists and translational researchers who are working to improve patient care with the ultimate goal of eradicating cancer.
When: Nov. 15-19, 2009
Where: Hynes Convention Center, Boston
'/>"/>
Contact: Natalie Poole
natalie.poole@aacr.org
267-646-0619
American Association for Cancer Research
Source:
Eurekalert
Linear Mode
